Extending the 5' non-coding sequence upstream of the T7 promoter prevents dsRNA formation, eliminating immune response stimulation without lowering RNA yields.
Silencing the beta-1,2-xylosyltransferase gene in Nicotiana benthamiana eliminates immunogenic xylose residues from therapeutic proteins.
Leucine-to-basic-amino-acid mutation in 2-O-sulfation enzyme resolves low activity bottleneck, enabling efficient heparin manufacturing.
Engineered PglB enzymes replace chemical coupling steps, streamlining glycoconjugate production and enhancing vaccine immunogenicity.
Specific amino acid substitutions in the AHAS enzyme enable sunflower tolerance to multiple herbicide families, resolving yield loss from weed competition.
ARS ribozyme attaches unnatural amino acids to initiator tRNA, enabling biosynthetic synthesis of unique N-terminal structures.
Deleting error-prone DNA polymerases in reduced genome bacteria lowers spontaneous mutation rates, resolving genetic instability during toxic gene expression.
Replacing optical sensors with ISFETs and synthesizing proteins in situ stabilizes arrays while enabling high-throughput kinase activity analysis.
Recombinase activation of endogenous genes separates treatment efficacy from disease reversibility, defining optimal therapeutic timeframes.
Supercomputing-assisted mutations extend the half-life of D-amino acid transaminase to over 12 hours at 40°C, overcoming rapid wild-type denaturation.
Recombinant testosteronan synthase produces a novel heparosan analog, avoiding complex animal-derived production and supply chain risks.
Segmenting large mirror-image proteins into smaller units resolves synthesis efficiency bottlenecks while maintaining functional activity.
Engineered microbial platforms replace complex chemical synthesis with enzymatic pathways for efficient 6′sialyllactose production.
Enzymatic sulfation using C4ST or C6ST replaces complex chemical synthesis, avoiding keratan sulfate contamination and bovine safety risks.
Inducible XIST transgene coats chromosome 21 to trigger heterochromatin formation and transcriptional silencing.
Engineered IRX10 polypeptides compete with native enzymes to reduce xylan polymer synthesis in plant biomass.
Engineered polymerase synthesizes modified RNA oligomers through template-directed enzymatic incorporation, overcoming solid-phase synthesis length limits.
Segmented enzymatic pathways in recombinant hosts resolve low yield and industrial scalability bottlenecks for methylated cinnamic acid production.
Deleting the FAE1 gene in recombinant camelina reduces gamma-linolenic acid accumulation while increasing eicosapentaenoic acid and docosahexaenoic acid yields.
Local quality principles guide asymmetric modification patterns that resolve the trade-off between nuclease resistance and cellular uptake efficiency.
Segmented fluorescent tags resolve background interference during cell-free synthesis detection.
Engineered polymerases synthesize orthogonal nucleic acid polymers like HNA and CeNA through targeted thumb region mutations.
Genetic modification of key enzymes increases mycosporine-like amino acid yields, resolving low productivity constraints in biosynthetic pathways.
Reducing ferulic acid via acyltransferase modulation increases soluble sugar yields and enhances biofuel production potential from biomass.
Engineering Cre recombinase into a heterotetramer with distinct subunits enables recombination at arbitrary asymmetric sites while reducing off-target effects.
Lipid acyltransferase converts phospholipids to cholesterol esters, reducing cholesterol without expensive protein emulsifiers.
Site-directed mutagenesis at positions L195P and S247G in plant EPSPS yields glyphosate resistance without exogenous genes, resolving public acceptance issues.
Transgenic bacteria express phenylpyruvate decarboxylase to synthesize tyrosol, replacing low-yield plant extraction with high-efficiency fermentation.
Replacing detergents with free arginine and cryoprotectants prevents protein denaturation, extending polymerase shelf-life nine-fold.
Non-functional mutant polymerase proteins stabilize active enzymes, eliminating detergent interference with downstream applications.